A Systems View Across Time and Space
From: On valuing biopharmaceutical product pipelines: an effectuation model and evidence
Canonical correlation analysis for Function 1 and 2 | |||||||
---|---|---|---|---|---|---|---|
Function 1 | Function 2 | ||||||
Variable | Coef | r s | r s 2 | Coef | r s | r s 2 | h 2 (%) |
Sales | 1.032 | 0.999 | 99.80 % | 1.326 | 0.019 | 0.04 % | 99.84 % |
Income | −0.037 | 0.897 | 80.51 % | −1.541 | −0.256 | 6.57 % | 87.08 % |
MarketVa | −0.030 | 0.117 | 1.38 % | 0.746 | 0.725 | 52.59 % | 53.97 % |
PriceEar | −0.027 | −0.210 | 4.41 % | 0.140 | 0.273 | 7.45 % | 11.85 % |
r c 2 | 90.20 % | 33.00 % | |||||
RnDExpen | 0.943 | 0.988 | 97.55 % | 0.846 | 0.023 | 0.05 % | 97.61 % |
RnDperce | −0.155 | −0.314 | 9.87 % | −0.094 | −0.004 | 0.00 % | 9.88 % |
ValuePip | −0.030 | −0.661 | 43.72 % | 1.308 | 0.749 | 56.17% | 99.90 % |